Home » York Pharma Acquires Anti-Infective Topical Derm Line From Solvay
York Pharma Acquires Anti-Infective Topical Derm Line From Solvay
York Pharma has announced the acquisition of the sales and worldwide commercial rights to two dermatological products from the Belgian Pharmaceutical and Chemical Company Solvay for a total consideration of €28.5m.
Objective Capital
Objective Capital
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May